science
Study Shows CD4+ T Cells Respond to Epstein-Barr Virus in Multiple Sclerosis
@ScienceMagazine reported that a research team identified immune mechanisms linking Epstein-Barr virus to multiple sclerosis. CD4+ T cells from patients responded to viral components, and B cell-depleting therapy reduced that response.
Jul 20, 11:00 PM·1m read1 source
SC
insurancejournal.comAudio version
Tap play to generate a narrated version.
Developing·Limited corroboration so far. This page will refresh as more sources emerge.
CD4+ T cells from patients with multiple sclerosis responded to components of Epstein-Barr virus particles in a study that identified immune mechanisms linking the virus to the disease, @ScienceMagazine reported. The same research found that B cell-depleting therapy calmed that response in patients who received the treatment.
The findings detail how the viral response operates and how existing therapy affects it. No other outcomes or patient data were included in the report.
Transparency
How sources framed this
SC
SC
Single source — no framing comparison available.
CorroborationModerate · 1 source
